BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36717034)

  • 1. Cholesterol metabolism pathway in autism spectrum disorder: From animal models to clinical observations.
    Lin J; de Rezende VL; de Aguiar da Costa M; de Oliveira J; Gonçalves CL
    Pharmacol Biochem Behav; 2023 Feb; 223():173522. PubMed ID: 36717034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders.
    Benachenhou S; Laroui A; Dionne O; Rojas D; Toupin A; Çaku A
    Int Rev Neurobiol; 2023; 173():115-139. PubMed ID: 37993175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autism Symptoms in Fragile X Syndrome.
    Niu M; Han Y; Dy ABC; Du J; Jin H; Qin J; Zhang J; Li Q; Hagerman RJ
    J Child Neurol; 2017 Sep; 32(10):903-909. PubMed ID: 28617074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.
    Rizk M; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
    Mol Biol Rep; 2021 Mar; 48(3):2669-2686. PubMed ID: 33650079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of communication repair skills across three neurodevelopmental disabilities.
    Martin GE; Barstein J; Patel S; Lee M; Henry L; Losh M
    Int J Lang Commun Disord; 2020 Jan; 55(1):26-42. PubMed ID: 31538707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of hypocholesterolemia in autism spectrum disorder and its associated comorbidities: A retrospective case-control study.
    Benachenhou S; Etcheverry A; Galarneau L; Dubé J; Çaku A
    Autism Res; 2019 Dec; 12(12):1860-1869. PubMed ID: 31385649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass Spectrometry for the Study of Autism and Neurodevelopmental Disorders.
    Wormwood KL; Ngounou Wetie AG; Ryan JP; Darie CC; Woods AG
    Adv Exp Med Biol; 2019; 1140():477-499. PubMed ID: 31347066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder.
    El-Ansary A; Bjørklund G; Chirumbolo S; Alnakhli OM
    Metab Brain Dis; 2017 Aug; 32(4):1209-1221. PubMed ID: 28497358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome.
    Jasoliya M; Gu J; AlOlaby RR; Durbin-Johnson B; Chedin F; Tassone F
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental divergence: motor trajectories in children with fragile X syndrome with and without co-occurring autism.
    Will EA; Bishop SL; Roberts JE
    J Neurodev Disord; 2019 Oct; 11(1):23. PubMed ID: 31586494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autism Spectrum Disorder Symptoms in Infants with Fragile X Syndrome: A Prospective Case Series.
    Hogan AL; Caravella KE; Ezell J; Rague L; Hills K; Roberts JE
    J Autism Dev Disord; 2017 Jun; 47(6):1628-1644. PubMed ID: 28281129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of lipid rafts cholesterol with clinical profile in fragile X syndrome.
    Toupin A; Benachenhou S; Abolghasemi A; Laroui A; Galarneau L; Fülöp T; Corbin F; Çaku A
    Sci Rep; 2022 Feb; 12(1):2936. PubMed ID: 35190617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Lipidomics in Autism Spectrum Disorder.
    El-Ansary A; Chirumbolo S; Bhat RS; Dadar M; Ibrahim EM; Bjørklund G
    Mol Diagn Ther; 2020 Feb; 24(1):31-48. PubMed ID: 31691195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting age related changes in autism spectrum disorder phenomenology in Cornelia de Lange, Fragile X, and Cri du Chat syndromes: Results from a 2.5 year follow-up.
    Cochran L; Moss J; Nelson L; Oliver C
    Am J Med Genet C Semin Med Genet; 2015 Jun; 169(2):188-97. PubMed ID: 25989416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multimethod Analysis of Pragmatic Skills in Children and Adolescents With Fragile X Syndrome, Autism Spectrum Disorder, and Down Syndrome.
    Martin GE; Bush L; Klusek J; Patel S; Losh M
    J Speech Lang Hear Res; 2018 Dec; 61(12):3023-3037. PubMed ID: 30418476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Cholesterol Biosynthetic Pathway Is Altered in a Preclinical Model of Fragile X Syndrome.
    Parente M; Tonini C; Buzzelli V; Carbone E; Trezza V; Pallottini V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights of altered lipid profile in Fragile X Syndrome.
    Çaku A; Seidah NG; Lortie A; Gagné N; Perron P; Dubé J; Corbin F
    PLoS One; 2017; 12(3):e0174301. PubMed ID: 28334053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double Genetic Hit: Fragile X Syndrome and Partial Deletion of Protein Patched Homolog 1 Antisense as Cause of Severe Autism Spectrum Disorder.
    Saldarriaga W; Payán-Gómez C; González-Teshima LY; Rosa L; Tassone F; Hagerman RJ
    J Dev Behav Pediatr; 2020 Dec; 41(9):724-728. PubMed ID: 32947579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.